Novartis Investor Presentation

16 SOC Outgrowth Medium 5.0-17 -0003ne 133 New Novartis: Our strategy Our focus > Our priorities Improved financials Launch excellence High-value innovation Our priorities Operational excellence Strengthen foundations Conclusion Abbreviations C Qube Nav1.1/1.4/1.5/17 60 mM sodium Novartis Investor Presentation | September 22, 2022 5mM calci 73 m TO U NOVARTIS | Reimagining Medicine Pipet-Lite XLS

View entire presentation